Related Experiment Videos
[Biochemical marker for myocardial injury]
Kenji Nakai1, Keiko Nakai, Akira Suwabe
1Department of Laboratory Medicine, Iwate Medical University, Morioka 020-8505.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|March 26, 2003
Summary
Troponin T and I (TnT/TnI) offer superior accuracy for diagnosing acute coronary syndromes (ACS) compared to older markers. Rapid whole-blood tests improve early detection in emergency settings.
Area of Science:
- Cardiology
- Biochemistry
- Emergency Medicine
Context:
- Established understanding of acute coronary syndrome (ACS) including myocardial infarction and unstable angina.
- Previous ACC/AHA guidelines (1996, 1999) stressed early diagnosis and treatment for myocardial infarction.
- Recent advances in myocardial injury biomarkers are reviewed for ACS management.
Purpose:
- To present recent advances in myocardial injury markers for acute coronary syndrome (ACS).
- To compare the diagnostic efficacy of troponin T/I (TnT/TnI) with creatinine kinase (CK/CK-MB).
- To highlight the utility of rapid detection systems for high-risk ACS cases.
Summary:
- Troponin T and I (TnT/TnI) demonstrate superior sensitivity and specificity for detecting myocardial injury over CK and CK-MB.
- Rapid whole-blood detection systems using TnT/TnI are valuable for diagnosing high-risk ACS.
- Revised ACC/ESC guidelines (2000) recommend TnT/TnI as the primary biochemical markers for myocardial injury, redefining myocardial infarction based on minimal injury.
Impact:
- TnT/TnI measurement is recommended for emergency room use, enhancing ACS diagnosis.
- Improved accuracy and rapid detection of myocardial injury can enhance diagnostic modality value.
- Future research may focus on inflammation markers like high-sensitivity C-reactive protein (hs-CRP) and activated platelets for ACS assessment.